Literature DB >> 11782045

Number needed to treat (NNT): estimation of a measure of clinical benefit.

S D Walter1.   

Abstract

The number needed to treat (NNT) is becoming increasingly popular as an index for reporting the results of randomized trials and other clinical studies. It represents the expected number of patients who must be treated with an experimental therapy in order to prevent one additional adverse outcome event (or, depending on the context, to expect one additional beneficial outcome), compared to the expected event rates under the control therapy. Although NNT is a clinically useful measure, little work has been done on its statistical properties. In this paper, alternative NNT-type measures are defined for use with discrete or continuous data. Estimators and their variances are obtained for these measures in cross-over or parallel group designs. The ideas are illustrated with data on quality of life in asthma patients. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11782045     DOI: 10.1002/sim.1173

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  17 in total

Review 1.  Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign.

Authors:  Jeanne Lenzer
Journal:  BMJ       Date:  2002-03-23

2.  Estimating clinically significant differences in quality of life outcomes.

Authors:  Kathleen W Wyrwich; Monika Bullinger; Neil Aaronson; Ron D Hays; Donald L Patrick; Tara Symonds
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

3.  Quantifying responsiveness of quality of life measures without an external criterion.

Authors:  Guang Yong Zou
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

4.  MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial.

Authors:  P Grossman; L Kappos; H Gensicke; M D'Souza; D C Mohr; I K Penner; C Steiner
Journal:  Neurology       Date:  2010-09-28       Impact factor: 9.910

5.  Exaggeration of treatment benefits using the "event-based" number needed to treat.

Authors:  Shawn D Aaron; Dean A Fergusson
Journal:  CMAJ       Date:  2008-09-23       Impact factor: 8.262

6.  The Depression Prevention Initiative: Impact on Adolescent Internalizing and Externalizing Symptoms in a Randomized Trial.

Authors:  Jessica S Benas; Alyssa E McCarthy; Caroline A Haimm; Meghan Huang; Robert Gallop; Jami F Young
Journal:  J Clin Child Adolesc Psychol       Date:  2016-09-20

7.  An economic evaluation of voriconazole versus amphotericin B for the treatment of invasive aspergillosis in Canada.

Authors:  Coleman Rotstein; Michel Laverdière; Anne Marciniak; Farzad Ali
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

8.  A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial.

Authors:  Solveig C Ligaarden; Lars Axelsson; Kristine Naterstad; Stian Lydersen; Per G Farup
Journal:  BMC Gastroenterol       Date:  2010-02-10       Impact factor: 3.067

9.  Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial.

Authors:  Jeffrey L Saver; Jeffrey Gornbein; James Grotta; David Liebeskind; Helmi Lutsep; Lee Schwamm; Phillip Scott; Sidney Starkman
Journal:  Stroke       Date:  2009-06-04       Impact factor: 7.914

10.  Estimating the number needed to treat from continuous outcomes in randomised controlled trials: methodological challenges and worked example using data from the UK Back Pain Exercise and Manipulation (BEAM) trial.

Authors:  Robert Froud; Sandra Eldridge; Ranjit Lall; Martin Underwood
Journal:  BMC Med Res Methodol       Date:  2009-06-11       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.